Activation of NF-kB by the cytoplasmic domains of HIV and SIV gp41
Activation of NF-kB by the cytoplasmic domains of HIV and SIV gp41
批准号:
8705773
负责人:
Michaela Ulrike Gack
金额:
$39.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-09 至 2015-07-31
关键词:
AffectArchitectureAttentionBindingBiochemicalBiochemical GeneticsCD4 Positive T LymphocytesCell Culture SystemCell physiologyCellsComplexCytoplasmic TailDependenceEnhancersEventExhibitsFoundationsGenesGenetic TranscriptionGlycoproteinsGrowthHIVHIV InfectionsHIV-1HumanImmune responseIn VitroInfectionInvestigationKineticsLaboratoriesLeadMacacaMediatingMediator of activation proteinModelingMolecularMonkeysMutationNF-kappa BNatural ImmunityNuclearPathogenesisPathogenicityPathway interactionsPhenotypePhosphorylationPhosphotransferasesPhysiologicalPropertyProvirusesRoleSIVSIV envelope protein gp41SeriesSignal PathwaySignal TransductionSignal Transduction PathwaySmall Interfering RNASubfamily lentivirinaeTissuesUbiquitinationViralViral GenesViral Load resultVirusVirus ReplicationWorkadaptive immunitybasecell typecomparativein vivoinsightmutantnew therapeutic targetnonhuman primatenovelnovel therapeuticspromotertranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
HIV, SIV, and related lentiviruses of other species are unusual in that their envelope glycoproteins have very long cytoplasmic domains (CD); however, investigation of the functional contributions of the unusually long CDs has received little attention. The proposed studies will build upon a recent discovery made by the Desrosiers laboratory, that the cytoplasmic domains of gp41 (gp41CD) of both HIV-1 and SIV induce robust activation of the transcription factor NF-?B. Binding studies further revealed that gp41CD of HIV-1, but not SIV, interacts specifically and efficiently with TGF-¿-activated Kinase 1 (TAK1), a key regulator of NF-?B signaling. Replication studies with wild-type HIV-1 and a mutant virus deficient in the ability to activate NF-?B demonstrated that NF-?B activation by gp41CD is important for the virus' ability to replicate in non- or minimally-activated CD4+ T-lymphocytes. These findings demonstrated a novel, evolutionarily conserved role for gp41CD in activating the NF-?B transcription factor. The proposed studies are directed toward investigating in precise detail how the cytoplasmic domains of gp41 (gp41CD) of HIV-1 and SIV lead to activation of NF-?B. Biochemical, genetic, and structural studies will focus on defining the signaling events, cellular interaction partners, and molecular mechanisms of gp41CD-induced NF-?B activation for promoting viral replication (Aim 1). Our studies will further determine the physiologic relevance of gp41CD-induced NF-?B activation for SIV replication and pathogenesis in vivo (Aim 2). Taken together, these studies will not only greatly expand our understanding of the modulation of key signaling pathways by HIV/SIV gp41, but may also define new therapeutic targets for the treatment of HIV infection in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ADAM9 in viral RNA sensing and antiviral innate immunity
-
批准号:10753041
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2023
-
负责人:Michaela Ulrike Gack
-
依托单位:
Defining the viral PTMome: Towards the development of novel antiviral approaches
-
批准号:10490866
-
项目类别:
-
资助金额:$112.7万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Defining the viral PTMome: Towards the development of novel antiviral approaches
-
批准号:10662495
-
项目类别:
-
资助金额:$112.7万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense
-
批准号:10338487
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense
-
批准号:10492729
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel Role for Host Immunostimulatory RNA in Antiviral Immune Defense
-
批准号:10676843
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
Defining the viral PTMome: Towards the development of novel antiviral approaches
-
批准号:10261712
-
项目类别:
-
资助金额:$112.7万
-
财政年份:2021
-
负责人:Michaela Ulrike Gack
-
依托单位:
The Role of TRIM23 in Autophagy Mediated Antiviral Defenses
-
批准号:10394983
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2020
-
负责人:Michaela Ulrike Gack
-
依托单位:
The Role of TRIM23 in Autophagy Mediated Antiviral Defenses
-
批准号:10623146
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2020
-
负责人:Michaela Ulrike Gack
-
依托单位:
The Role of TRIM23 in Autophagy Mediated Antiviral Defenses
-
批准号:10353335
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2020
-
负责人:Michaela Ulrike Gack
-
依托单位:
EBV infection control by RNA surveillance
-
批准号:10283975
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2019
-
负责人:Michaela Ulrike Gack
-
依托单位:
Novel innate immune sensing mechanisms of intracellular RNA
-
批准号:9375604
-
项目类别:
-
资助金额:$20.23万
-
财政年份:2017
-
负责人:Michaela Ulrike Gack
-
依托单位:
Flavivirus NS3-mediated Innate Immune Escape
-
批准号:9219701
-
项目类别:
-
资助金额:$52.72万
-
财政年份:2016
-
负责人:Michaela Ulrike Gack
-
依托单位:
Flavivirus NS3-mediated Innate Immune Escape
-
批准号:10290686
-
项目类别:
-
资助金额:$54.33万
-
财政年份:2016
-
负责人:Michaela Ulrike Gack
-
依托单位:
Flavivirus NS3-mediated Innate Immune Escape
-
批准号:9759756
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2016
-
负责人:Michaela Ulrike Gack
-
依托单位:
Regulatory mechanisms of the MDA5-mediated antiviral interferon response
-
批准号:8224496
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2012
-
负责人:Michaela Ulrike Gack
-
依托单位:
Regulatory mechanisms of the MDA5-mediated antiviral interferon response
-
批准号:8420260
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2012
-
负责人:Michaela Ulrike Gack
-
依托单位:
REGULATORY MECHANISMS OF THE MDA5-MEDIATED ANTIVIRAL INTERFERON RESPONSE
-
批准号:8357996
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2011
-
负责人:Michaela Ulrike Gack
-
依托单位:
RIG-I- AND TRIM25-MEDIATED IMMUNE RESPONSE AND EVASION OF INFLUENZA A VIRUS
-
批准号:8357995
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2011
-
负责人:Michaela Ulrike Gack
-
依托单位:
REGULATION OF RIG-I MEDIATED ANTIVIRAL INNATE IMMUNITY
-
批准号:8357994
-
项目类别:
-
资助金额:$16.64万
-
财政年份:2011
-
负责人:Michaela Ulrike Gack
-
依托单位:
海外基金